Point-of-Care Echocardiography With Assistance Technology

Study for Point-of-Care Echocardiography With Assistance Technology

Establish the effectiveness of the Bay Labs, Inc. EchoGPS software in enabling RNs to acquire echocardiograms. In this study an echocardiogram protocol using the EchoGPS interface with the Terason uSmart 3200t, an FDA 510(k)-cleared, commercially available ultrasound device will be performed. Participants will have two scans, one by a registered nurse (RN) using the Terason uSmart 3200t with EchoGPS (Study Exam) and one by a sonographer using the Reference Device without EchoGPS guidance (Control Exam), under the same protocol. Study is non-significant risk (NSR).

Study Overview

• Status: Completed
• Conditions: Cardiac Disease
• Intervention / Treatment: Diagnostic test: Diagnostic Test: Limited Echocardiogram

Detailed Description

To validate clinical use of Bay Labs, Inc. EchoGPS guidance software by registered nurses (RNs) with no prior scanning experience to acquire limited two-dimensional echocardiograms. In this study an echocardiogram protocol using the EchoGPS interface with the Terason uSmart 3200t, an FDA 510(k)-cleared, commercially available ultrasound device will be performed. Participants will have two scans, one by a registered nurse (RN) using the Terason uSmart 3200t with EchoGPS (Study Exam) and one by a sonographer using the Reference Device without EchoGPS guidance (Control Exam), under the same protocol. Study is non-significant risk (NSR).

• Study Type: Interventional
• Enrollment (Actual): 240
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Illinois
    • Chicago, Illinois, United States, 60611
      • Northwestern Medicine, Bluhm Cardiovascular Institute
  • Minnesota
    • Minneapolis, Minnesota, United States, 55407
      • Minneapolis Heart Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 14 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

All patients must meet the following inclusion criteria to participate in the study:

• Patients scheduled for an echocardiographic examination
• Patients ≥18 years old

Exclusion Criteria:

Patients must NOT meet any of the following exclusion criteria to participate in the trial:

• Unable to lie flat for study
• Patients experiencing a known or suspected acute cardiac event
• Patients with severe chest wall abnormalities
• Patients who have undergone pneumonectomy
• Patients unwilling or unable to give written informed consent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Patients scheduled for an echocardiogram; Patients ≥18 years scheduled for an echocardiographic examination. This is a non-randomized, un-blinded, study in patients with an indication for an echocardiographic examination. Enrolled patients will be stratified into two groups based on known cardiac abnormalities to ensure a sufficient number of patients with cardiac abnormalities and into 3 strata of BMI: normal, overweight and obese.

Diagnostic test: Diagnostic Test: Limited Echocardiogram; STUDY SOFTWARE non-significant risk (NSR) Bay Labs EchoGPS software interfaced with the Terason uSmart 3200t FDA 510(k)-cleared, commercially available ultrasound EchoGPS software communicates with the ultrasound image formation engine of the 510(k)-cleared Terason uSmart 3200t through an application programming interface (API). EchoGPS will be used to provide visual guidance feedback to users during image acquisition. For this study, RNs will use EchoGPS to perform limited echocardiogram examinations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Study-level Assessment	The primary endpoints for the study are separate patient-level assessments of whether the patient study is of adequate image quality to make a qualitative visual assessment for a particular clinical parameter (ie., Yes/No). Expert cardiologist readers will independently provide assessments and they will be blinded to the assessments from the other readers as well as whether the images were acquired by an RN or sonographer. The Outcome Measure will be reported as the percentage of patient studies for which the panel of cardiologist readers adjudicated as being of sufficient image quality to make a particular clinical assessment.	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
View-level Assessment	The Outcome Measure will be reported as the percentage of patient studies with diagnostic quality clip for a particular Standard View acquired in the study. Expert cardiologist readers will independently provide assessments and they will be blinded to the assessments from the other readers as well as whether the images were acquired by an RN or sonographer.	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Inter-User Variability (Primary Clinical Parameters)	o Comparison of user variability for primary clinical parameters (measured as the coefficient variation for binary assessment of whether the study is of diagnostic quality to make a particular clinical assessment)	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Inter-User Variability (Acquisition Time)	o View level acquisition time (minutes and seconds)	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Patient-Level Acquisition time	o Patient level acquisition time (minutes and seconds)	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
View-Level Acquisition time	o View-level acquisition time (minutes and seconds)	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Comparison of study exam and control exam (View-Level Results)	o Comparison of View level results measured as percent agreement of images with diagnostic quality	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Comparison of study exam and control exam (Patient-Level Results)	o Comparison of patient level results measured as percent agreement of patient exams of sufficient quality to make a particular clinical assessment	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments
Comparison of study exam and control exam (Task-Based Assessment)	o Comparison of qualitative assessments from study and control exam to assess whether cardiologists reach a similar decision with study exam images and control exam images	Up to 2 months from the completion of the study or when all expert cardiologists readers independently complete their assessments

Collaborators and Investigators

• Sponsor: Sara Guttas
• Investigators: Principal Investigator: Akhil Narang, MD, Northwestern Medicine, Bluhm Cardiovascular Institute

Study record dates

Study Major Dates

• Study Start (Actual): March 25, 2019
• Primary Completion (Actual): May 23, 2019
• Study Completion (Actual): May 23, 2019

Study Registration Dates

• First Submitted: March 23, 2019
• First Submitted That Met QC Criteria: March 28, 2019
• First Posted (Actual): April 1, 2019

Study Record Updates

• Last Update Posted (Actual): September 17, 2019
• Last Update Submitted That Met QC Criteria: September 13, 2019
• Last Verified: September 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Heart Diseases
• Other Study ID Numbers: EchoGPSPivotal1.0

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Yes
• IPD Plan Description: Individual participant data (IPD) will not be made available to other researchers.
• IPD Sharing Time Frame: N/A - IPD will not be made available to other researchers.
• IPD Sharing Access Criteria: N/A - IPD will not be made available to other researchers.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: No